Search

1 to 10 of 170
Sort by

Web Page
SITC Publishes Clinical Practice Guideline on Immune Checkpoint Inhibitor-related Adverse Events

FOR IMMEDIATE RELEASE July 14, 2021 MILWAUKEE – The Society for Immunotherapy of Cancer (SITC), the world's leading member-driven organization dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy, is pleased to announce the publication...


Event
CPG Webinar – Case Studies in Immune Effector Cell-related Adverse Events

On Wednesday, October 13, 2021 from 5:30–6:30 p.m. ET, join leading experts from the SITC Immune Effector Cell-related Adverse Events Guideline Expert Panel for the "SITC Clinical Practice Guideline Webinar – Case Studies in Immune Effector Cell-related Adverse Events." This high-level webinar...

 10-13-2021 | 17:30 - 18:30 ET


Library Entry
SITC CPG Webinar - Practical Management Pearls for Immunotherapy for the Treatment of Lymphoma - Recorded Webinar and Presentation Slides

On Monday, June 21, 2021 from 4 – 5 pm ET, leading experts from the SITC Lymphoma Immunotherapy Guideline Expert Panel presented "SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immunotherapy for the Treatment of Lymphoma." This high-level webinar was designed so that...

2 attachments


Library Entry
SITC Clinical Practice Guideline Webinar - Case Studies in Immunotherapy for the Treatment of Multiple Myeloma

On June 16, 2021, leading experts in cancer immunotherapy presented an advanced webinar focused on "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma." This high-level webinar was designed so that attendees will be able to...

2 attachments


Library Entry
SITC Clinical Practice Guidelines Webinar - Practical Management Pearls for Immunotherapy for the Treatment of Multiple Myeloma - Recorded Webinar and Presentation Slides

On April 23, 2021, leading experts in cancer immunotherapy presented an adv anced webinar focused on "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma." This webinar was designed for attendees to be able to appraise and classify...

2 attachments





Library Entry
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

Immune effector cell (IEC) therapies offer durable and sustained remissions in significant numbers of patients with hematological cancers. While these unique immunotherapies have improved outcomes for pediatric and adult patients in a number of disease states, as ‘living drugs,’ their toxicity...